Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/E ratio is N/A as of 2026-10-06T14:57:38.354Z.
Calculation as of: 2026-10-06T14:57:38.354Z.
Quote observation: 2026-10-06T14:55:22.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: e161c80cfac107eb20fb361b69cb0f235817b8c251747178931ba3815a78b5f6
PE RATIO
N/A
PE RATIO AVG TTM
N/A
PE RATIO AVG 3Y
N/A
PE RATIO AVG 5Y
N/A
PE RATIO AVG 10Y
N/A
PE RATIO AVG 15Y
N/A
PE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$136.65M
PE Ratio
N/A
TTM Avg
1879.79
3Y Avg
1257.96
5Y Avg
875.52
Market Cap
$140.03M
PE Ratio
N/A
TTM Avg
194.70
3Y Avg
73.96
5Y Avg
73.96
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| LifeMD, Inc. (LFMD) | $135.17M | N/A | N/A | N/A | N/A |
| KORU Medical Systems, Inc. (KRMD)vs › | $136.65M | N/A | 1879.79 | 1257.96 | 875.52 |
| Freenome, Inc. (FRNM)vs › | $133.37M | N/A | N/A | N/A | N/A |
| Fortress Biotech, Inc. (FBIOP)vs › | $139.73M | 6.62 | 6.25 | 6.25 | 6.25 |
| Organigram Global Inc. (OGI)vs › | $131.22M | 2.09 | 9.74 | 18.49 | 18.49 |
| AirSculpt Technologies, Inc. (AIRS)vs › | $140.03M | N/A | 194.70 | 73.96 | 73.96 |
| Alpha Cognition Inc (ACOG)vs › | $138.69M | N/A | N/A | N/A | N/A |
| Health Catalyst, Inc. (HCAT)vs › | $129.68M | N/A | N/A | N/A | N/A |
| Nyxoah S.A. (NYXH)vs › | $143.10M | N/A | N/A | N/A | N/A |
| Immuneering Corporation (IMRX)vs › | $144.48M | N/A | N/A | N/A | N/A |
Trailing P/E
N/A
Forward P/E
N/A
Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.
Calculation:
Current Price
$2.79
Forward EPS (Est.)
$-0.52
Forward P/E
N/A
Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PE RATIO |
|---|---|
| 2018-08-17 | 21.67 |
| 2018-08-16 | 22.50 |
| 2018-08-15 | 24.17 |
| 2018-08-14 | 23.33 |
| 2018-08-13 | 22.50 |
| 2018-08-10 | 19.17 |
| 2018-08-09 | 19.17 |
| 2018-08-08 | 17.50 |
| 2018-08-07 | 18.33 |
| 2018-08-06 | 20.00 |
| 2018-08-03 | 20.00 |
| 2018-08-02 | 20.00 |
| 2018-08-01 | 20.00 |
| 2018-07-31 | 20.00 |
| 2018-07-30 | 20.00 |
| 2018-07-27 | 20.00 |
| 2018-07-26 | 20.00 |
| 2018-07-25 | 18.33 |
| 2018-07-24 | 18.33 |
| 2018-07-23 | 19.17 |
| 2018-07-20 | 18.33 |
| 2018-07-19 | 17.50 |
| 2018-07-18 | 17.50 |
| 2018-07-17 | 17.50 |
| 2018-07-16 | 16.67 |
| 2018-07-13 | 17.50 |
| 2018-07-12 | 17.50 |
| 2018-07-11 | 17.50 |
| 2018-07-10 | 18.33 |
| 2018-07-09 | 17.50 |
| 2018-07-06 | 14.17 |
| 2018-07-05 | 14.17 |
| 2018-07-03 | 18.33 |
| 2018-07-02 | 18.33 |
| 2018-06-29 | 18.33 |
| 2018-06-28 | 15.83 |
| 2018-06-27 | 19.17 |
| 2018-06-26 | 16.67 |
| 2018-06-25 | 16.67 |
| 2018-06-22 | 19.17 |
| 2018-06-21 | 18.33 |
| 2018-06-20 | 18.33 |
| 2018-06-19 | 19.17 |
| 2018-06-18 | 15.83 |
| 2018-06-15 | 16.67 |
| 2018-06-14 | 15.83 |
| 2018-06-13 | 16.67 |
| 2018-06-12 | 18.33 |
| 2018-06-11 | 20.83 |
| 2018-06-08 | 20.00 |
| 2018-06-07 | 20.83 |
| 2018-06-06 | 20.00 |
| 2018-06-05 | 18.33 |
| 2018-06-04 | 20.00 |
| 2018-06-01 | 20.00 |
| 2018-05-31 | 19.17 |
| 2018-05-30 | 20.00 |
| 2018-05-29 | 20.00 |
| 2018-05-25 | 21.67 |
| 2018-05-24 | 20.83 |
| 2018-05-23 | 19.17 |
| 2018-05-22 | 20.00 |
| 2018-05-21 | 17.50 |
| 2018-05-18 | 20.00 |
| 2018-05-17 | 20.83 |
| 2018-05-16 | 20.00 |
